Position in SVRA
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$774,164
+$220,127 QoQ
Shares Held
125,676
+23.9% QoQ
Ownership
0.061%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#71
of 181 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in SVRA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026PRICE T ROWE ASSOCIATES INC /MD/ holds $17,555,962,932 across 304 Biotechnology names. SVRA ranks #180 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
2,678,047 | $2,484,611,664 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,529,709 | $953,834,749 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,728,421 | $858,558,562 | |
| 4 | KYMR |
Kymera Therapeutics, Inc.
|
7,112,980 | $815,645,416 | |
| 5 | RPRX |
Royalty Pharma plc
|
11,193,657 | $627,628,347 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
2,969,853 | $447,655,945 | |
| 7 | MRNA |
Moderna, Inc.
|
5,589,560 | $391,436,886 | |
| 8 | SRRK |
Scholar Rock Holding Corp
|
6,794,837 | $373,716,035 |
All Filings in SVRA
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $774,164 | 125,676 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $554,037 | 101,472 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $419,302 | 69,536 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $240,689 | 67,420 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $126,920 | 55,667 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $144,377 | 52,122 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $134,060 | 43,668 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $162,951 | 38,432 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $124,865 | 30,984 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $167,786 | 33,692 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $136,614 | 29,067 | Shares | Defined | 2024-02-16 | |
| 2023-09-30 | $103,269 | 27,320 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $113,611 | 35,559 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $56,472 | 28,960 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $44,888 | 28,960 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $44,888 | 28,960 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $34,595 | 22,760 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $28,636 | 21,860 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $21,402 | 17,260 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $23,818 | 17,260 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $29,342 | 17,260 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $39,526 | 19,003 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $13,573 | 11,803 | Shares | Sole | 2021-02-16 | |
| No filing history on record for this holder in this stock. | ||||||